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1012-21 Systemic Arterial Compliance in Patients With Aortic 
Stenosis: Relationship With Diastolic Dysfunction 
Philippe Pibarot Jean G. Dumesnil, lsabelle Laforest, Martin Briand. Antonio Tongue, 
Lyes Kadem, Quebec Heart Institute/ Lava1 Hospital, Sam@Foy, PQ, Canada 
Background: Diastolic dysfunction (DD) in aortic stenosis (AS) does not always correlate 
to classical markers of hemodynamic severity and it has been hypothesized that other 
factors may be involved. In an acute animal model, we recently observed that a decrease 
in systemic arterial compliance (SAC) downstream lo a severe AS was associated with a 
marked increase in peak LV systolic wall stress and a decrease in aortic diastolic pres- 
sure. Since both abnormalities may predispose to the development of DD, we hypothe- 
sized that SAC might have a significant impact on DD in patients with AS. 
Methods: Relevant clinical and echocardiographic variables were measured in 226 con- 
secutive patients (128 males, 96 females, mean age: 69*12 years) with at least moder- 
ate AS (Aorlic Valve Area (AVA) cl.5 cm2). Total SAC was calculated as follows: Total 
SAC=SV/(SAP-DAP), where SAP and DAP are systolic and diastolic blood pressures 
measured at the time of stoke volume (SV) measurement 
Results: One hundred and eighty eight (166, 83%) patients had DD (abnormal relaxation: 
114 pts, 50%; pseudo-normal: 66 pts, 30%; and restrictive: 6 pts, 3%). Patients with DD 
were older (71 *ll vs. 61*14 years; p<O.OOl) and they had a smaller AVA (0.95iO.26 vs. 
1.09*0.27 cm2; p=O.O03), a lower radius-to-wall-thickness ratio (2.06+0.46 vs. 
2.40*0.49; pcO.OOl), a lower total SAC (1.22+0.45 vs. 1.61+0.57 ml/mmHg; p<O.OOl), 
and higher incidence of systemic hypertension (72 vs 39%, p<O.OOl). However, in multi- 
variate analysis, the only variables independently associated with DD were radius-to- 
wall-thickness ratio (p=O.O09), AVA (p=O.O3) and total SAC (p<O.O004). 
Conclusion: In patients with moderate or severe AS, systemic arterial compliance is more 
closely associated to DD than the classical markers of stenosis severity. These results 
suggests that, beyond the stenosis severity and the degree of concentric LV hypertrophy, 
it is also important to consider the anatomic and hemodynamic factors involved down- 
stream to the stenosis since they may have lmporiant Implications regarding the LV func- 
tion and thus the prognosis of these patients. 
1012-22 Hypercholesterolemic Valvulopathy as an Aspect of 
Malignant Atherosclerosis 
Akito Kawaquchi, Chikao Yutani, Akira Yamamoto, National Cardiovascular Center, 
Osaka, Japan 
Background; Aortic stenosis is frequently observed in young patients with homozygous 
famtlial hypercholesterolemia (FH). Some patients with heterozygous FH also affect not 
only coronary artery, but also the aortic valve resulting in aorltc valve replacement (AVR). 
Methods; We reviewed 10 homozygous (25.7il6.5 years) and 39 heterozygous FH 
patients under age 60 years (47.4i7.4 years) on evolution and prevalence of the aortlc 
valvular dysfunction by sequential catheterization and echocardiography for 2 decades. 
Surgically excised aortic cusps obtained from the patients with homozygous FH. het- 
erozygous FH and non-FH calcific aorlic stenosis were histopathologically examined. 
Results; Nine patients with homozygous FH had aoriic regurgitation, 3 of them have 
aggravated transaorlic pressure gradients more than 70mmHg and 2 patients received 
AVR at 20 and 31 years-old. The initial clinical sign was cusp thickening and the develop- 
ment of a regurgitant jet followed by increaseing pressure gardienst across the aortic 
valve despite of intensive cholesterol-lowering therapy. Ten of 39 heterozygous FH 
patients had aorlic regurgitation with impaired distensibility of the ascending aorta. 
Pathological examination demonstrated that the earliest change in the cusp is thickening 
of the fibrosa with the infiltration of foam cells, macrophages stained by HAM-64 and T- 
lymphocytes stamed with anti CD-45. The nature of the changes of FH valves were simi- 
lar to the histopathological changes seen in the age-related calcific aorhc stenosis that 
occurs in the non-FH population. Conclusions; Hypercholesterolemia affects the aortic 
valve which occurs in a short period of time in homozygous FH patients by extreme 
hypercholesterolemla, over an intermediate time period in heterozygous FH pakents with 
several risk factors and over a number of years gradualy in the elder non-FH population 
with additional nsk factors and underlying mild hypercholesterolemia. Histopathological 
changes of the cusps are common in these patients with AVR. Aortic stebnosis as hyper- 
cholesterolemic valvulopathy I?. a life-threatening complication as the pnmary clinical 
characteristic of malignant atherosclerosis. 
1012-23 Do Statins Really Slow the Progression of Aortic Valve 
Stenosis? A Need for a Prospective Randomized Trial 
Francesco Antonini-Canterin, Guoqian Huang. Eugenio Cervesato, Pompilio Faggiano, 
Daniela Pawn, Rita Piazza, Angiola Bolis. Antonio Ciavaiione, Albert0 Ruggiero, 
Gianluigi Nicolosi. A.R.C. Cardiologia. Pordenone, Italy 
Background. It has been recently suggested an a retrospectwe study of 57 statin-treated 
patients with mild to moderate aortic stenosis (AS) that statins could slow the progression 
of AS. 
Methods. From our echocardiographic database (1966-2001) we obtained 95 StatIn- 
treated patients wth mild to moderate AS (initial peak aortic velocity 2-3.9 m/s) and with 
at least two examinations >6 months one apart of the other (61 males, 34 females, mean 
age 67.6 r 6.6 years, mean follow up 54 & 36 months; Initial aortic valve area 1.26 f 0.26 
cm2). As control group we randomly selected, from the remaining 759 patients with an 
initially similar degree of AS and with at least two examinations, 95 sex-age matched 
patients who did not receive treatment with a statin (61 males, 34 females, mean age 
67.5 * 6.7 years, mean follow up 51 * 34 months; initial aortic valve area 1.28 * 0.25 
cm2). 
Results. The rate of increase of peak aortic velocity was 0.15 f 0.26 m/s/y in the statin 
group and 0.15 * 0.20 m/sly in the control group (p=ns). The rate of decrease of aortic 
valve area was - 0.074 * 0.095 cm2iy m the statin group and 0.069 f 0.074 cm2iy in the 
control group (p=ns). The mean value of aortic valve area at the end of the study was 
1 .Ol * 0.31 cm2 in the statin group and 1.04 * 0.30 cm2 in the controls (p=ns). A pattern 
of rapid progression of AS (increase of peak aoriic velocity > 0.3 m/s/y) was observed in 
20/95 (21%) of statin-treated patients and in 15/95 (16%) patients who did not receive 
statins (p=ns). A major clinlcal end point (death or aortic valve replacement) was found in 
21/95 statin-treated patients (22%) and in 13/95 (14%) not treated patients (p=ns). 
Conclusion. Despite the theoretical potential benefits of statins on aortlc valve lesion. our 
study does not confirm the first results about their slowing effect on the progression of 
AS. A prospective randomized controlled trial is necessary before to extend the indica- 
tions of the statins in patients with AS. 
1012-24 C-Reactive Protein Is Increased in Aortic Stenosis but 
Not Aortic Regurgitation 
lvor L. Gerber, Christopher J. Hammett, Ralph A. Stewart, Helen Oxenham. John K. 
French, Teena M. West, Malcolm E. Legget, Harvey D. White, Green Lane Hospital, 
Auckland, New Zealand, University of Auckland, Auckland, New Zealand 
Introduction: Histological ewdence of inflammation similar to that observed in athero- 
sclerosis has been reported in aorllc stenosis (AS), but not in aortic regurgitation (AR). 
Aim: To determine whether serum levels of C-reactive protern (CRP), a marker of inflam- 
mation, are elevated in AS and/or AR. 
Methods: Transthoracic echocardiography was performed, and CRP was measured by 
high-sensitivity enzyme immunoassay in 20 patients with isolated non-rheumatic AS, 
mean age 67 * 11 years, 19 patients with isolated non-rheumatic AR, mean age 45 * 14 
years, and in 31 controls, mean age 66 r 4 years. Exclusion criteria for all subjects were 
history of cardiac failure, cerebrovascular disease, peripheral vascular disease, cancer, 
recent development of any actwe inflammatory or haematological disorder, left ventricu- 
lar ejection fraction < 50%, and the presence of coronary stenosis >50% determined by 
coronary angiography (m all patients with AS and I” 6 patients with AR). The other 11 AR 
patients had no symptoms of angina and no regional wall motion abnormalities on 
echocardiography. All controls were free of cardiovascular disease as determined by his- 
tory, physical examination, exercise ECG and echocardiography. 
Results: Mean * SD echocardiographic measures for AS were: peak aortic velocity 4.6 f 
0.7 m/s, aortic valve area 0.77 * 0.25 cm2, and LV ejection fraction 62 * 7%. and for AR, 
LV end-diastolic diameter 6.9 * 0.6 cm and LV ejection fraction 56 * 5%. CRP was 
increased in AS compared with controls, median (interquartile range) 2.96 (1.59-5.37) 
mgll vs. 1.51 (0.75-2.09) mgll, P=O.O07, but not in AR compared with controls, 1.00 
(0.35-2.00) mg/l. P=O.66 after adjusting for age. There were no significant correlations 
between CRP and echocardiographic measures of valve disease severity for AS or AR, 
P > 0.05 for all. 
Conclusion: Serum levels of CRP are raised in patients with non-rheumatic aoriic steno- 
sis, but not in non-rheumatic aortic regurgitation. This data supports the hypothesis there 
is an active inflammatory component lo non-rheumatic aoriic stenosis. 
1012-25 Cardiovascular Risk Factors in Patients With Aortic 
Stenosis Are Associated With the Prevalence of 
Coronary Artery Disease, but Not the Prevalence of 
Aortic Stenosis 
Jan R. Ortle~g Fabian Schmltz, Vera Mevissen, Tolga Bozoglu, Peter Hanrath, Rainer 
Hoffmann. University Hospital of Aachen, Aachen. Germany 
Background: Traditional cardiovascular risk factors have been associated with aoriic 
stenosis and coronary artery disease (CAD). However, the profile of cardiovascular risk 
factors in patients with aortic stenosis has not been compared with the profile of controls 
matched for gender, age and CAD defined by left coronary anglography. 
Methods: 523 patients referred for elective diagnostic left heart catherization because of 
severe aortic stenosis formed the case population. 3925 patvents referred for elective 
diagnostic left heart catherizatlon without valve disease formed the base control popula- 
tion. Out of these, 523 patients were pair matched to the case population for gender, age 
and prevalence of relevant CAD and formed the pair matched control population. In all 
patients the cardiovascular risk profile (male gender, hypertension, hypercholester- 
olemia, smoking, diabetes mellitus, family history for CAD) was assessed. 
Results: None of the traditional cardiovascular risk factors was more prevalent in patients 
with aortic stenosis compared to the base control population or compared with the pair 
matched control population. However, male gender, hypercholesterolemia, smoking, dia- 
betes mellitus. family history for CAD were significantly associated with the presence of 
additional CAD in patients with aortic stenosis. 
Conclusions: Cardiovascular risk factors are frequently present III patients with aortic 
stenosis. They are significantly associated with the prevalence of CAD. However, if com- 
pared to conBoIs matched for age, gender and anglographIc defined CAD no risk factor 
was associated wrth the prevalence of aortic stenosis itself. 
